Literature DB >> 29374638

Fluctuating hypercalcaemia caused by cavitary Mycobacterium bovis pulmonary infection.

Darren Patrick Moloney1, Liam Chawke1, Mairead Therese Crowley2, Terence M O'Connor1.   

Abstract

Hypercalcaemia occurs in many granulomatous diseases. Among them, sarcoidosis and tuberculosis are the most common causes. Other causes include berylliosis, coccidioidomycosis, histoplasmosis, Crohn's disease, silicone-induced granulomas, cat-scratch disease, Wegener's granulomatosis and Pneumocystis carinii pneumonia. Hypercalcaemia in granulomatous disease occurs as a consequence of dysregulated production of 1,25-(OH)2 D3 (calcitriol) by activated macrophages in granulomas. Hypercalcaemia in patients with Mycobacterium tuberculosis infection has been reported in 0%-28% of cases. Uncultured bronchoalveolar lavage cells from patients with M. tuberculosis produce greater amounts of calcitriol compared with controls. Although Nayar et al described hypercalcaemia in a case of sepsis associated with intravesical Bacille Calmette Guerin therapy, there are no published reports describing hypercalcaemia in patients with pulmonary M. bovis infection. We describe a patient with M. bovis cavitary pulmonary infection with sustained hypercalcaemia that fluctuated and recurred repeatedly over the course of therapy, ultimately culminating in normalisation of serum calcium when therapy had led to cure. Treatment consisted of antituberculous therapy, oral corticosteroids and intravenous bisphosphonates with a favourable outcome. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acute renal failure; calcium and bone; endocrine system; tb and other respiratory infections; tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 29374638      PMCID: PMC5786893          DOI: 10.1136/bcr-2017-222351

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease.

Authors:  X Bosch
Journal:  Gastroenterology       Date:  1998-05       Impact factor: 22.682

Review 2.  Endocrine aspects of sarcoidosis.

Authors:  J L Winnacker; K L Becker; S Katz
Journal:  N Engl J Med       Date:  1968-02-22       Impact factor: 91.245

Review 3.  Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature.

Authors:  J D Stoeckle; H L Hardy; A L Weber
Journal:  Am J Med       Date:  1969-04       Impact factor: 4.965

4.  Hypercalcemia in disseminated candidiasis.

Authors:  H M Kantarjian; M F Saad; E H Estey; R V Sellin; N A Samaan
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

Review 5.  Vitamin D metabolite-mediated hypercalcemia.

Authors:  J S Adams
Journal:  Endocrinol Metab Clin North Am       Date:  1989-09       Impact factor: 4.741

6.  Does tuberculosis really cause hypercalcemia?

Authors:  F Keleştimur; M Güven; M Ozesmi; H Paşaoğlu
Journal:  J Endocrinol Invest       Date:  1996-11       Impact factor: 4.256

7.  Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong.

Authors:  C C Shek; A Natkunam; V Tsang; C S Cockram; R Swaminathan
Journal:  Q J Med       Date:  1990-12

8.  Low incidence of hypercalcaemia in tuberculosis in Malaysia.

Authors:  T T Tan; B C Lee; B A Khalid
Journal:  J Trop Med Hyg       Date:  1993-12

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.

Authors:  Ekaterina V Kurbatova; Joseph S Cavanaugh; Tracy Dalton; Eleanor S Click; J Peter Cegielski
Journal:  Clin Infect Dis       Date:  2013-07-09       Impact factor: 9.079

View more
  1 in total

1.  Repeated bouts of pulmonary tuberculosis in a hunting cat: reinfection or recrudescence?

Authors:  Carolina Sc Albuquerque; Petra Černá; Danièlle A Gunn-Moore
Journal:  JFMS Open Rep       Date:  2021-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.